Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.66 SEK | -2.62% | -10.85% | +92.69% |
Jun. 26 | Diamyd Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2024 | CI |
May. 16 | Diamyd Medical AB Updates on the Registrational Phase 3 Trial | CI |
Chart calendar Diamyd Medical AB
Upcoming events on Diamyd Medical AB
Past events on Diamyd Medical AB
2024-06-25 | Q3 2024 Earnings Release |
2024-03-26 | Q2 2024 Earnings Release |
2024-01-23 | Q1 2024 Earnings Release |
2023-11-29 | Annual General Meeting |
2023-10-24 | BioStock Life Science Fall Summit |
2023-10-20 08:00 am | Business Update Call |
2023-10-10 | Q4 2023 Earnings Release |
2023-06-28 02:15 am | Q3 2023 Earnings Release |
2023-06-26 04:00 am | Extraordinary Shareholder Meeting |
2023-05-24 12:00 am | Redeye Theme Diabetes Forum |
2023-04-04 | Q2 2023 Earnings Release |
2023-01-24 | Q1 2023 Earnings Release |
2022-11-30 | Annual General Meeting |
2022-10-04 | FY 2022 Earnings Release |
2022-09-19 | EASD Conference |
2022-06-22 02:15 am | Q3 2022 Earnings Release |
2022-03-29 | Interim 2022 Earnings Release |
2022-01-25 | Q1 2022 Earnings Release |
2021-12-01 | Annual General Meeting |
2021-10-05 | FY 2021 Earnings Release |
Annual results
Fiscal Period | August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 1,64 1,00 63.7% | 1,13 0,50 125% | 0,25 0,60 -57.83% | 0,45 0,00 - | 19,6 3,00 553.73% | 3,00 |
EBITDA Million SEK | Released Forecast Spread | -36,4 -41,0 11.15% | 9,89 13,6 -27.29% | -85,1 -73,2 -16.25% | -112 -110 -2.21% | -100 -117 14.47% | -132 |
EBIT Million SEK | Released Forecast Spread | -36,6 -44,0 16.89% | 9,74 13,4 -27.32% | -85,9 -74,0 -16.05% | -115 -114 -0.82% | -105 -122 13.98% | -134 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -36,6 -44,0 16.8% | 9,71 14,2 -31.63% | 60,0 71,8 -16.37% | -104 -102 -1.49% | -100 -122 17.86% | -133 |
Net income Million SEK | Released Forecast Spread | -36,6 -44,0 16.8% | 9,71 14,2 -31.63% | 60,0 71,8 -16.37% | -104 -102 -1.49% | -100 -122 17.86% | -133 |
EPS SEK | Released Forecast Spread | -0,50 -0,62 19.35% | 0,10 0,20 -50% | 0,90 0,81 11.11% | -1,40 -1,30 -7.69% | -1,30 -1,42 8.45% | -1,33 |
Announcement Date | 02/10/19 | 07/10/20 | 13/10/21 | 05/10/22 | 11/10/23 | - |
Past sector events for Diamyd Medical AB
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-08 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-07 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-06 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
2024-06-06 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DMYD B Stock
- Calendar Diamyd Medical AB